Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mangoceuticals (MGRX) Operating Expenses (2023 - 2025)

Historic Operating Expenses for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $7.6 million.

  • Mangoceuticals' Operating Expenses rose 31254.08% to $7.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 11091.52%. This contributed to the annual value of $8.4 million for FY2024, which is 1345.47% down from last year.
  • Latest data reveals that Mangoceuticals reported Operating Expenses of $7.6 million as of Q3 2025, which was up 31254.08% from $5.4 million recorded in Q2 2025.
  • Mangoceuticals' 5-year Operating Expenses high stood at $7.6 million for Q3 2025, and its period low was $1.8 million during Q4 2024.
  • Moreover, its 3-year median value for Operating Expenses was $2.5 million (2024), whereas its average is $3.3 million.
  • Per our database at Business Quant, Mangoceuticals' Operating Expenses crashed by 3515.29% in 2024 and then soared by 31254.08% in 2025.
  • Over the past 3 years, Mangoceuticals' Operating Expenses (Quarter) stood at $2.7 million in 2023, then tumbled by 35.15% to $1.8 million in 2024, then surged by 332.02% to $7.6 million in 2025.
  • Its Operating Expenses stands at $7.6 million for Q3 2025, versus $5.4 million for Q2 2025 and $4.9 million for Q1 2025.